Puma Biotechnology, Inc. Ratios

Ratios Dec2009 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 79.87%86.21%86.48%82.51%74.84%77.96%73.40%72.06%
EBT Margin -1,054.20%-45.24%-27.75%-26.56%-11.38%0.18%9.62%10.46%
EBIT Margin -1,056.13%-37.71%-14.34%-13.51%-2.39%9.49%13.85%13.44%
EBITDA Margin -1,056.13%-37.71%-14.34%-13.51%-2.39%9.49%13.85%13.44%
Operating Margin -1,056.13%-37.71%-14.34%-13.51%-2.39%9.49%13.85%13.44%
Net Margin -1,054.56%-45.25%-27.77%-26.65%-11.51%0.00%9.16%10.07%
FCF Margin -698.30%-623.07%-9.67%8.11%0.32%8.16%-6.33%11.40%16.86%
Efficiency
Inventory Average 2.33M2.90M3.31M5.28M5.82M5.80M7.90M
Assets Average 212.32M247.01M239.56M235.40M224.32M226.29M221.93M
Equity Average -0.02M43.80M25.88M5.76M-4.20M9.58M37.52M72.78M
Invested Capital -0.05M101.78M186.19M112.42M8.34M-2.45M21.61M87.44M137.45M
Asset Utilization Ratio 1.181.100.941.081.111.041.04
Leverage & Solvency
Interest Coverage Ratio -406.10-8.62-2.60-2.16-0.472.052.452.49
Debt to Equity 5.44-16.52-39.694.551.860.73
Debt Ratio 0.400.400.430.440.430.31
Equity Ratio 0.320.130.07-0.02-0.010.100.230.43
Times Interest Earned -406.10-8.62-2.60-2.16-0.472.052.452.49
Valuation
Enterprise Value -0.00M3,628.10M610.63M229.26M313.82M42.19M111.98M203.91M48.75M
Market Capitalization 3,709.79M776.05M340.91M407.96M124.29M193.06M299.85M149.72M
Return Ratios
Return on Sales -10.54%-0.45%-0.28%-0.27%-0.12%0.00%0.09%0.10%
Return on Capital Employed -0.65%-0.25%-0.24%-0.05%0.16%0.26%0.25%
Return on Invested Capital 0.01%0.57%0.27%
Return on Assets -0.53%-0.31%-0.25%-0.12%0.00%0.10%0.10%
Return on Equity -2.59%-2.92%-10.42%6.94%0.00%0.58%0.32%